Rahoton Zurfi Kan Kasuwar Endoscopy ta 2025 ta China

Cikakken Bayani game da "Wasan Kursiyu" akan Teburin Biliyan 4.57

Shekarar 2025 ta sake fuskantar wani karuwar girgizar ƙasa a Kasuwar GI Endoscopy ta ƙasar Sin. Sabbin bayanai daga YiZhaoCai sun nuna jimillar darajar kasuwa ta ¥4.57 biliyan (RMB), wadda ta ƙunshi jimillar tsarin da aka tsara guda 1,735 da kuma jimillar ... 

Wannan rahoto, wanda ya dogara ne akan bayanai na musamman daga YiZhaoCai, ya bayar da cikakken bincike game da wannan "Game of Thrones" wanda darajarsa ta kai ¥ biliyan 4.57 daga manyan fannoni guda huɗu: Yanki, Alamar Kasuwanci, Sayayya ta Tsakiya, da Sabbin Masu Shiga. 

I. Gasar Yanki: Sichuan, Jiangsu, da Guangdong Sun Jagoranci Gasar; Manyan Larduna 10 Sun Kai Sama da Kashi 57% na Kasuwa

Bukatar siyan na'urorin endoscope na GI yana da alaƙa sosai da ƙarfin tattalin arzikin yanki da matakan ci gaban kiwon lafiya. A cikin 2025, kasuwa ta nuna tasirin "maida hankali kan kai".

Sichuan (9.86%) sun yi nasara a kan matsayi na farko, inda suka zama babbar kasuwar GI endoscopy a duk faɗin ƙasar. Ana iya danganta wannan da ƙarfin "tasirin rage kiba" ga lardunan da ke maƙwabtaka a matsayin "Cibiyar Kiwon Lafiya ta Yamma." Bayan haka, Jiangsu (9.28%) da Guangdong (6.51%) sun sami manyan matsayi uku, suna amfani da ƙarfin tattalin arzikinsu mai ƙarfi da kuma yawan jama'a. Abin lura shi ne, larduna goma mafi girma sun kai kashi 57.08% na jimillar kason kasuwa, wanda ke nuna ƙaruwar tasirin Matthew.

II. Rikicin Alamar Kasuwanci: Ƙasashen Waje vs. Na Cikin Gida, Ƙarƙashin Ruwa a cikin "Kishiya Mai Ƙarfi Huɗu"

Gasar cinikayya ta 2025 ta wakilci rikici kai tsaye tsakanin manyan 'yan wasan ƙasashen waje biyu da manyan 'yan wasan cikin gida biyu. Bayanai daga fannoni daban-daban sun nuna sarkakiya da ƙarfin wannan fafatawar.

Babban Rahoton: Daidaiton Daraja da Girma

A cikin ma'aunin darajar tallace-tallace mai mahimmanci, Olympus (35.63%) da Fujifilm (33.56%) sun kasance masu rinjaye gaba ɗaya, tare da jimlar hannun jarinsu da ke kusa da kashi 70%, wanda ke nuna babban ramin su a kasuwa mai tsada. Daga cikin samfuran cikin gida, SonoScape (13.96%) da Aohua (11.41%) suna riƙe da matsayinsu a matakin farko.

Duk da haka, yayin da aka canza hangen nesa zuwa yawan tallace-tallace, Fujifilm (29.40%) ya zarce Olympus (27.26%), wanda ke nuna yawan jigilar kayayyaki na Fujifilm a kasuwar matsakaici. SonoScape (17.85%) da Aohua (17.72%) sun ci gaba da kasancewa iri ɗaya a cikin girma kamar yadda yake a cikin daraja, yana nuna cewa "musanya farashi da girma" ya kasance babban dabarar samfuran cikin gida a wannan matakin.

Filin Yaƙin Siyayya Mai Tsaka-tsaki: "Fa'idar Gida" ta Wutar Lantarki ta Cikin Gida

Sayen da aka yi a tsakiya (sayen da aka yi bisa ga girma) yana aiki a matsayin "tushen tabbatarwa" mafi inganci don lura da maye gurbin gida.

A cikin yawan sayayya da aka yi a tsakiya, Aohua (50.27%) ta mamaye rabin kasuwa da cikakken fa'ida, inda ta zama babbar mai nasara a wannan fanni. Wannan ya nuna saurin martanin da take bayarwa ga manufofi da dabarun farashi mai sassauƙa. SonoScape (18.03%) shi ma ya yi aiki mai kyau sosai.

Dangane da darajar siyayya ta tsakiya, Fujifilm (31.48%) da Olympus (28.26%) har yanzu suna kan gaba, suna dogara da manyan samfuran su. Duk da haka, Aohua (27.47%) sun bi sahun gaba, ba tare da wani gibi ba, suna nuna cewa dabarun ta na sayayya ta tsakiya ba wai kawai ya dogara ne akan ƙananan farashi ba; ta kuma yi nasarar gabatar da samfuran matsakaici zuwa manyan.

III. Tashi na Sabbin Masu Shiga: Wanene Zai Zama "Mai Canza Wasan" Na Gaba?

Yayin da manyan 'yan kasuwa ke fafatawa a cikin mawuyacin hali, ƙungiyar "sabbin masu shiga" tana taruwa a hankali. A cikin shekaru biyar da suka gabata, adadin kamfanonin da NMPA ta amince da su shiga kasuwar endoscopy ya ƙaru kowace shekara.

Sabbin Kamfanonin Endoscope na GI da NMPA ta Amince da su (2021-2025)

An Sauri Amincewa, Sabbin 'Yan Wasa Sun Shiga

Tun daga shekarar 2023, tsarin amincewa da NMPA don kayayyakin endoscopy ya yi sauri sosai. A shekarar 2025, adadin sabbin rajista (63) da sabbin kamfanoni (7) sun kai kololuwa, sakamakon ƙarfafa manufofin ƙasa don na'urorin likitanci na cikin gida da kuma himmar neman jari daga masana'antu.

"Star Enterprises" Shiga Fagen Wasan

Jerin waɗanda suka shiga gasar ya yi fice, inda ya ƙunshi manyan kamfanonin na'urorin likitanci irin na dandamali kamar MicroPort, United Imaging, Wego, Lepu Medical, da UE Medical. Shigarsu, wanda ke da goyon bayan bincike da ci gaba, ƙarfin kuɗi, da kuma ƙarfin hanyoyin sadarwa masu yawa, yana haifar da ƙalubale na dogon lokaci ga tsarin kasuwar da ake da shi.

IV. Ƙarshe da Gabatarwa

Kasuwar Endoscopy ta China ta 2025 tana da alaƙa da gasa mai ƙarfi inda "Yaƙin Kasuwa Mai Girma" ya kasance tare da "Yaƙin Tsaka-tsaki zuwa Ƙarƙashin Ƙasa da Tsakiya." Kayayyakin ƙasashen waje suna kare ribar kasuwa mai girma tare da fa'idodin fasaha da alama. Sabanin haka, samfuran cikin gida, waɗanda ke bin ƙa'idodin tallafi, suna faɗaɗa yawan su cikin sauri ta hanyar siye-siye na tsakiya da kuma shiga cikin ƙananan kasuwanni yayin da suke ci gaba da turawa cikin ɓangaren manyan kamfanoni.

Idan aka yi la'akari da gaba, tare da cikakken shigar manyan kamfanoni kamar MicroPort da United Imaging, da kuma sabbin masu fafatawa kamar UE Medical, gasar kasuwa za ta ƙara ƙarfi. Kirkirar fasaha, kula da farashi, da zurfin hanyoyin sadarwa za su haɗa kai wajen tantance waɗanda suka yi nasara a zagaye na gaba na sake fasalin kasuwa.

Bayanin Tushen Bayanai:

Kamfanin Beijing YiBai ZhiHui Data Consulting Co., Ltd. ne ya samar da bayanan matsayi a cikin wannan rahoton, bisa ga abin da yake ɗauka a matsayin abin dogaro kuma bayanai da jama'a ke samu a halin yanzu.

An samo bayanai kan sabbin kamfanoni daga Endoscopy Vision flex Industry Notes.

#Endoscopy na hanji #Na'urorin lafiya #Binciken Kasuwa #Sauya a Gida

Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China wanda ya ƙware a fannin amfani da endoscopic, gami da layin GI kamar suƙarfin biops, ƙwanƙwasa jini, tarkon polyp, allurar sclerotherapy, feshi catheter,gogewar cytology, waya mai jagora, Kwandon ɗaukar dutse, cathete na magudanar biliary na hancida sauransu. wanda ake amfani da shi sosai a cikin EMR, ESD, ERCP. Kuma Layin Urology, kamar rufin shiga ureteralda kuma rufin shiga ureteral tare da tsotsa,dKwandon Duba Dutse Mai Fitsari Mai Iya Samuwa, da kuma jagorar urology da sauransu.

Kayayyakinmu an ba su takardar shaidar CE, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma suna ba wa abokin ciniki yabo da yabo sosai!